Gofen & Glossberg LLC Renalytix PLC Transaction History
Gofen & Glossberg LLC
- $3.89 Billion
- Q4 2022
A detailed history of Gofen & Glossberg LLC transactions in Renalytix PLC stock. As of the latest transaction made, Gofen & Glossberg LLC holds 188,224 shares of RNLX stock, worth $28,233. This represents 0.01% of its overall portfolio holdings.
Number of Shares
188,224
Previous 187,224
0.53%
Holding current value
$28,233
Previous $240,000
46.67%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding RNLX
# of Institutions
29Shares Held
3.91MCall Options Held
13.7KPut Options Held
0-
Pinnacle Associates LTD847KShares$126,9800.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY555KShares$83,2500.01% of portfolio
-
Tejara Capital LTD London, X0499KShares$74,8650.05% of portfolio
-
Stifel Financial Corp St. Louis, MO489KShares$73,4140.0% of portfolio
-
Ci Private Wealth, LLC Miami, FL336KShares$50,3270.0% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $5.62M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...